Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelogenous Leukemia

Explore clinical trials studying Chronic Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

112 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelogenous Leukemia trial results

Completed

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

NCT02081378

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +13 more
Locations
  • Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center SC Ann Arbor, Michigan, United States
  • Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering New York, United States
  • Oregon Health Sciences University SC-6 Portland, Oregon, United States
View all 18 locations
View Trial Details
Completed

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

NCT02639559

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +38 more
Locations
  • Northside Hospital Cancer Institute Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

NCT03625388

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +12 more
Locations
  • King Hussein Cancer Center (KHCC) Amman, Jordan
  • Jordan University Hospital (JUH) Amman, Jordan
  • American University of Beirut Medical Center (AUBMC) Beirut, Lebanon
  • The King Faisal Specialist Hospital and Research Centre (KFSH&RC) Riyadh, Saudi Arabia
View Trial Details
Completed

A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor

NCT01696461

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +31 more
Locations
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

NCT02743351

Conditions
Acute Graft-versus-host Disease, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +35 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California, San Diego (UCSD) Moores Cancer Center San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
View all 15 locations
View Trial Details

Related conditions